CRVL

Q: What is the price of CorVel (CRVL) today?

The current price of CorVel (CRVL) is $ 54.96, representing a -52.44% gain over the past year. The stock began the year trading around $ 67.67 and is currently priced at $ 54.96. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does CorVel (CRVL) pay dividends?

CorVel (CRVL) did not pay dividends over the past year.

Q: Is CorVel (CRVL) a good investment?

CorVel (CRVL) is currently trading at $ 54.96 with a P/E ratio of 26.27%. This represents a 4,614% premium compared to its historical average P/E. Over the past year, the stock has gained -52.44 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -52.44%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

CorVel Corporation

Price

$ 54.96

return (12m)

-52.44%

p/e

26.27

p/bv

7.39

DIVIDEND YIELD

0.00%

CRVL price

CRVL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CRVL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.54%

3 months

-23.67%

1 year

-52.44%

2 years

-77.09%

5 years

-48.97%

10 years

36.78%

Fundamentals CRVL

review the fundamentals of CorVel shares

P/E

26.27

Sector: -2.15 Industry: 0.38

P/S (PSR)

2.95

Sector: 1.92 Industry: 2.43

P/BV

7.39

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

16.40%

Sector: -25.33% Industry: -23.48%

ROE

28.14%

Sector: -29.65% Industry: -31.19%

ROIC

29.19%

Sector: -418.66% Industry: -76.94%

NET MARGIN

11.23%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

24.20%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

14.52%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

18.20

Sector: -0.40 Industry: 1.11

EV/EBIT

20.31

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

4.31

Sector: 1.13 Industry: 1.20

BVPS

7.37

Sector: 3.83 Industry: 5.09

EPS

2.07

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.58

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.42

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

8.70%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

11.42%

Sector: - Industry: -

FAIR VALUE OF CorVel ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 54.96

Fair Value

$ 0.00

Upside/Downside Return potential.

-66.29%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CRVL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CRVL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CorVel

CorVel Corporation

Average Investor10 user rating

4.0 (2 people)

United States

39 years

Founded: 1987

1991

Time since IPO - 35 years

3.681

Employees

CorVel Corporation (United States) is listed on the Nasdaq and has a market capitalization of $2.78 Billions, with shareholders equity totaling $375.72 Millions.

The company employs approximately 3.681 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, CorVel Corporation reported $941.48 Millions in revenue, generating net income of $105.73 Millions.

Key financial metrics include a P/E ratio of 26.27, a price-to-book (P/B) ratio of 7.39, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRVL.

Market cap

$ 2.78 Billions

Net worth

$ 375.72 Millions

$ 375,720,000.00

Assets

$ 644.78 Millions

$ 644,780,000.00

Total Shares Outstanding

51.00 Millions

51,000,000

Average Daily Trading Volume

$ 268.09 Thousand

$ 268,085.82

Sector

Health

Industry

Health Establishments

CRVL

CRVL revenue and profits

Financial Results CRVL

DRAG THE FRAME TO SEE MORE DATA

CRVL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 78.22 16,76% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 274.25 --12,48% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 36.31 --42,02% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.15 --29,63% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 489.58 45,61% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 931.09 30,10% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 151.18 53,77% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34